Παρακολούθηση
Michelino De Laurentiis
Michelino De Laurentiis
Istituto Nazionale Tumori Napoli "Fondazione Pascale", Napoli, ITALY
Η διεύθυνση ηλεκτρονικού ταχυδρομείου έχει επαληθευτεί στον τομέα istitutotumori.na.it
Τίτλος
Παρατίθεται από
Παρατίθεται από
Έτος
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials
Early Breast Cancer Trialists' Collaborative Group
The Lancet 365 (9472), 1687-1717, 2005
79882005
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials
Early Breast Cancer Trialists' Collaborative Group
The Lancet 366 (9503), 2087-2106, 2005
63682005
Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 …
Early Breast Cancer Trialists' Collaborative Group
The Lancet 378 (9804), 1707-1716, 2011
41102011
Tamoxifen for early breast cancer: an overview of the randomised trials
Early Breast Cancer Trialists' Collaborative Group
The Lancet 351 (9114), 1451-1467, 1998
40121998
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials
EBCTC Group
The lancet 378 (9793), 771-784, 2011
31882011
Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years’ adjuvant treatment for breast cancer
A Howell, J Cuzick, M Baum, A Buzdar, M Dowsett, JF Forbes, ...
Lancet 365 (9453), 60-62, 2005
29872005
Trastuzumab emtansine for residual invasive HER2-positive breast cancer
G Von Minckwitz, CS Huang, MS Mano, S Loibl, EP Mamounas, M Untch, ...
New England Journal of Medicine 380 (7), 617-628, 2019
25242019
Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials
EBCTC Group
The Lancet 379 (9814), 432-444, 2012
23162012
Polychemotherapy for early breast cancer: an overview of the randomised trials
Early Breast Cancer Trialists' Collaborative Group
The Lancet 352 (9132), 930-942, 1998
21661998
Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC …
A The
The Lancet 359 (9324), 2131-2139, 2002
21112002
Palbociclib in hormone-receptor–positive advanced breast cancer
NC Turner, J Ro, F André, S Loi, S Verma, H Iwata, N Harbeck, S Loibl, ...
New England Journal of Medicine 373 (3), 209-219, 2015
18062015
20-year risks of breast-cancer recurrence after stopping endocrine therapy at 5 years
H Pan, R Gray, J Braybrooke, C Davies, C Taylor, P McGale, R Peto, ...
New England Journal of Medicine 377 (19), 1836-1846, 2017
16752017
Adjuvant pertuzumab and trastuzumab in early HER2-positive breast cancer
G Von Minckwitz, M Procter, E De Azambuja, D Zardavas, M Benyunes, ...
New England Journal of Medicine 377 (2), 122-131, 2017
16232017
Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials
Early Breast Cancer Trialists' Collaborative Group
The Lancet 386 (10001), 1341-1352, 2015
14042015
Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials
Early Breast Cancer Trialists' Collaborative Group
The Lancet 355 (9217), 1757-1770, 2000
12832000
Phase III randomized study of ribociclib and fulvestrant in hormone receptor–positive, human epidermal growth factor receptor 2–negative advanced breast cancer: MONALEESA-3
DJ Slamon, P Neven, S Chia, PA Fasching, M De Laurentiis, SA Im, ...
Journal of Clinical Oncology 36 (24), 2465-2472, 2018
10862018
Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer
Early Breast Cancer Trialists' Collaborative Group
New England journal of medicine 319 (26), 1681-1692, 1988
10711988
Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial
D Tripathy, SA Im, M Colleoni, F Franke, A Bardia, N Harbeck, SA Hurvitz, ...
The lancet oncology 19 (7), 904-915, 2018
10492018
Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early‐stage breast cancer: results of the ATAC …
ATAC (Arimidex, Tamoxifen Alone or in Combination) Trialists' Group
Cancer 98 (9), 1802-1810, 2003
9082003
Overall survival with ribociclib plus fulvestrant in advanced breast cancer
DJ Slamon, P Neven, S Chia, PA Fasching, M De Laurentiis, SA Im, ...
New england Journal of medicine 382 (6), 514-524, 2020
7892020
Δεν είναι δυνατή η εκτέλεση της ενέργειας από το σύστημα αυτή τη στιγμή. Προσπαθήστε ξανά αργότερα.
Άρθρα 1–20